A new study reveals that entacapone, a drug used to treat Parkinson’s disease, significantly disrupts the gut microbiome by ...

A new study has revealed that the widely prescribed Parkinson's disease drug entacapone significantly disrupts the human gut microbiome by inducing iron deficiency. The findings, published in ...

Expert Rev Neurother. 2009;9(7):929-940. Improvements in levodopa pharmacokinetics with the addition of entacapone were similar to that seen in healthy volunteers. In addition, Phase II trials ...

Carbidopa 50mg, levodopa 200mg, entacapone 200mg; tabs. Swallow whole; max one tablet per dosing interval. Previously on carbidopa/levodopa and entacapone: substitute on a mg/mg basis. Stalevo 50 ...

Levodopa is the most efficacious agent for the treatment of motor features of Parkinson's disease but its chronic use is associated with the development of motor complications. Mounting evidence ...